{
      "Rank": 409,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Patients receive no interventions after rectal cancer treatment.",
            "Patients receive NeuroRegen scaffold transplantation after rectal cancer treatment.",
            "Patients receive autologous bone marrow mononuclear cells with NeuroRegen scaffold transplantation after rectal cancer treatment.",
            "Patients receive allogeneic human umbilical cord mesenchymal stem cells with NeuroRegen scaffold transplantation after rectal cancer treatment."
      ],
      "ArmGroupInterventionName": [
            "Procedure: Laparoscopic surgery",
            "Device: NeuroRegen scaffold transplantation",
            "Biological: NeuroRegen scaffold/BMMCs transplantation",
            "Biological: NeuroRegen scaffold/HUC-MSCs transplantation"
      ],
      "ArmGroupLabel": [
            "Laparoscopic surgery",
            "NeuroRegen scaffold transplantation",
            "NeuroRegen scaffold/BMMCs transplantation",
            "NeuroRegen scaffold/HUC-MSCs transplantation"
      ],
      "ArmGroupType": [
            "Sham Comparator",
            "Experimental",
            "Experimental",
            "Experimental"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT02648386"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "Erectile dysfunction (ED) is one of the commonest complications in men after rectal cancer treatment. The purpose of this study is to assess the safety and efficacy of autologous bone marrow mononuclear cells (BMMCs) or allogeneic human umbilical cord-derived mesenchymal stem cells (HUC-MSCs) combined with NeuroRegen scaffold transplantation in men with erectile dysfunction after rectal cancer treatment."
      ],
      "BriefTitle": [
            "Stem Cell Therapy Combined With NeuroRegen Scaffold\u2122 in Patients With Erectile Dysfunction After Rectal Cancer Surgery"
      ],
      "CentralContactEMail": [
            "13913957628@163.com",
            "sufanghan22@genetics.ac.cn"
      ],
      "CentralContactName": [
            "Yutian Dai, M.D.",
            "Sufang Han, Ph.D."
      ],
      "CentralContactPhone": [
            "86-25-83106666",
            "86-10-82614420"
      ],
      "CentralContactPhoneExt": [
            "70502"
      ],
      "CentralContactRole": [
            "Contact",
            "Contact"
      ],
      "CollaboratorClass": [
            "OTHER"
      ],
      "CollaboratorName": [
            "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School"
      ],
      "CompletionDate": [
            "December 2020"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Rectal Cancer",
            "Erectile Dysfunction"
      ],
      "ConditionAncestorId": [
            "D000015179",
            "D000007414",
            "D000005770",
            "D000004067",
            "D000009371",
            "D000009369",
            "D000004066",
            "D000005767",
            "D000007410",
            "D000012002",
            "D000012735",
            "D000020018",
            "D000001523"
      ],
      "ConditionAncestorTerm": [
            "Colorectal Neoplasms",
            "Intestinal Neoplasms",
            "Gastrointestinal Neoplasms",
            "Digestive System Neoplasms",
            "Neoplasms by Site",
            "Neoplasms",
            "Digestive System Diseases",
            "Gastrointestinal Diseases",
            "Intestinal Diseases",
            "Rectal Diseases",
            "Sexual Dysfunction, Physiological",
            "Sexual Dysfunctions, Psychological",
            "Mental Disorders"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BXS",
            "BXM",
            "All",
            "BC04",
            "BC06"
      ],
      "ConditionBrowseBranchName": [
            "Urinary Tract, Sexual Organs, and Pregnancy Conditions",
            "Behaviors and Mental Disorders",
            "All Conditions",
            "Neoplasms",
            "Digestive System Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Erectile Dysfunction",
            "Rectal Cancer"
      ],
      "ConditionBrowseLeafId": [
            "M9369",
            "M13998",
            "M17042",
            "M9600",
            "M8038",
            "M6408",
            "M8035",
            "M6407",
            "M9596",
            "M13996",
            "M14698",
            "M21026",
            "M13625",
            "M3967"
      ],
      "ConditionBrowseLeafName": [
            "Erectile Dysfunction",
            "Rectal Neoplasms",
            "Colorectal Neoplasms",
            "Intestinal Neoplasms",
            "Gastrointestinal Neoplasms",
            "Digestive System Neoplasms",
            "Gastrointestinal Diseases",
            "Digestive System Diseases",
            "Intestinal Diseases",
            "Rectal Diseases",
            "Sexual Dysfunction, Physiological",
            "Sexual Dysfunctions, Psychological",
            "Psychotic Disorders",
            "Mental Disorders"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000012004",
            "D000007172"
      ],
      "ConditionMeshTerm": [
            "Rectal Neoplasms",
            "Erectile Dysfunction"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "Double"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [
            "Participant",
            "Outcomes Assessor"
      ],
      "DetailedDescription": [],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nDiagnosed with local rectal cancer, which is within 12cm from anus.\nMale, 20-65 years old.\nIIEF-5 score> 21.\nNo obvious abnormal in external genitalia, testis, epididymis and spermatic cord.\nHave a consistent partner who is willing to engage in sexual activity more than twice per month during the study.\nSigned informed consent.\nRecently take no drugs affecting sexual function (such as androgen replacement drugs, PDE5i and Chinese patent medicine, etc.).\n\nExclusion Criteria:\n\nSuffering hypertension or diabetes.\nIn the investigators judgment, with clinical significance of penis abnormalities, or has received penile prosthesis implantation surgery.\nPatient's partner is trying to conceive during the trial period.\nExposure to any investigational drug or procedure within 1 month prior to study entry or enrolled in a concurrent study that may confound results of this study.\nGeographically inaccessible for follow-up visits required by protocol or want to other treatment."
      ],
      "EnrollmentCount": [
            "34"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "Male"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "Laparoscopic surgery",
            "NeuroRegen scaffold transplantation",
            "NeuroRegen scaffold/BMMCs transplantation",
            "NeuroRegen scaffold/HUC-MSCs transplantation"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "Completely resected rectal tumor.",
            "After completely resected rectal tumor, exposed pelvic autonomic nerves, and then transplanted NeuroRegen scaffold to the nerve.",
            "Completely resected rectal tumor, exposed pelvic autonomic nerves, and then transplanted NeuroRegen scaffold loaded with 5 million bone marrow mononuclear cells to the nerve.",
            "Completely resected rectal tumor, exposed pelvic autonomic nerves, and then transplanted NeuroRegen scaffold loaded with 5 million human umbilical cord mesenchymal cells to the nerve."
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "Laparoscopic surgery",
            "NeuroRegen scaffold transplantation",
            "NeuroRegen scaffold/BMMCs transplantation",
            "NeuroRegen scaffold/HUC-MSCs transplantation"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Procedure",
            "Device",
            "Biological",
            "Biological"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [
            "Recruiting"
      ],
      "LastUpdatePostDate": [
            "January 25, 2019"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "January 23, 2019"
      ],
      "LeadSponsorClass": [
            "OTHER_GOV"
      ],
      "LeadSponsorName": [
            "Chinese Academy of Sciences"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Nanjing"
      ],
      "LocationContactEMail": [
            "13913957628@163.com",
            "zhuleilei68n@163.com"
      ],
      "LocationContactName": [
            "Yutian Dai, M.D.",
            "LeiLei Zhu, M.D."
      ],
      "LocationContactPhone": [
            "86-25-83106666",
            "86-25-83106666"
      ],
      "LocationContactPhoneExt": [
            "70502",
            "70502"
      ],
      "LocationContactRole": [
            "Contact",
            "Contact"
      ],
      "LocationCountry": [
            "China"
      ],
      "LocationFacility": [
            "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School"
      ],
      "LocationState": [
            "Jiangsu"
      ],
      "LocationStatus": [
            "Recruiting"
      ],
      "LocationZip": [
            "210008"
      ],
      "MaximumAge": [
            "65 Years"
      ],
      "MinimumAge": [
            "20 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Bone Marrow Mononuclear Cells or Human Umbilical Cord-derived Mesenchymal Stem Cells Combined With NeuroRegen Scaffold\u2122 Transplantation for the Improvement of Erectile Function in Men After Rectal Cancer Surgery"
      ],
      "OrgClass": [
            "OTHER_GOV"
      ],
      "OrgFullName": [
            "Chinese Academy of Sciences"
      ],
      "OrgStudyId": [
            "CAS-XDA-ED-IGDB"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "Chinese Academy of Sciences"
      ],
      "OverallOfficialName": [
            "Jianwu Dai, Ph.D."
      ],
      "OverallOfficialRole": [
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Unknown status"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 1",
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "December 2020"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [],
      "PrimaryOutcomeMeasure": [
            "Safety and Tolerability assessed by Adverse Events"
      ],
      "PrimaryOutcomeTimeFrame": [
            "Up to 6 months"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [
            "Chinese Academy of Sciences"
      ],
      "ResponsiblePartyInvestigatorFullName": [
            "Jianwu Dai"
      ],
      "ResponsiblePartyInvestigatorTitle": [
            "Principal Investigator of Regenerative Medicine Laboratory, Institute of Genetics and Developmental Biology, CAS"
      ],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Principal Investigator"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "Improvements in sexual function based on the (IIEF)-5 questionnaire",
            "Changes in mean scores of Sexual Encounter Profile (SEP) Question 2 and 3 will be evaluated and reported.",
            "Changes in penile cavernosal artery peak systolic velocity in [cm/s] as determined by Penile colour Doppler ultrasonography combined with prostaglandin-E1 injection.",
            "Monitor penis erection during sleep to assess erection function of the patients.",
            "To assess the penile sensory pathway abnormalities of the patients with or without premature ejaculation.",
            "Change of the maximum flow rate (Qmax) to assess the bladder function."
      ],
      "SecondaryOutcomeMeasure": [
            "IIEF-5 (International Index of Erectile Function)",
            "Mean scores of the Sexual Encounter Profile (SEP) Question 2, 3",
            "Penile cavernosal artery peak systolic velocity (PSV)",
            "Nocturnal penile tumescence (NPT)",
            "The change of results of Nerve electrophysiological examination",
            "Maximum Flow Rate (Qmax)"
      ],
      "SecondaryOutcomeTimeFrame": [
            "1, 3, 6, 12 months",
            "1, 3, 6, 12 months",
            "1, 3, 6, 12 months",
            "1, 3, 6, 12 months",
            "1, 3, 6, 12 months",
            "1, 3, 6, 12 months"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "January 2016"
      ],
      "StartDateType": [],
      "StatusVerifiedDate": [
            "December 2015"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "January 7, 2016"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "January 5, 2016"
      ],
      "StudyFirstSubmitQCDate": [
            "January 5, 2016"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}